Patents by Inventor William Olson

William Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124554
    Abstract: The present relates to VEGF traps and VEGF mini-traps that include VEGF receptor Ig-like domains, fused to a multimerizing component, which bind to VEGF and block its interaction with the VEGF receptor. Such molecules are useful for treating angiogenic eye disorders (e.g., age-related macular degeneration), cancer and for other undesired angiogenesis.
    Type: Application
    Filed: October 6, 2023
    Publication date: April 18, 2024
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: William OLSON, Joel Martin, Neil Stahl, Jee Kim
  • Patent number: 11958910
    Abstract: Provided herein are bispecific antigen-binding molecules that bind HER2 and methods of use thereof. The bispecific antigen-binding molecules comprise a first and a second antigen-binding domain, wherein the first and second antigen-binding domains bind to two different (preferably non-overlapping) epitopes of the extracellular domain of human HER2. The bispecific antigen-binding molecules cluster on the surface of HER2 IHC2+ and IHC3+ cells, and are internalized into the cellular lysosomes. Also included are antibody-drug conjugates (ADCs) comprising the antibodies or bispecific antigen-binding molecules provided herein linked to a cytotoxic agent, radionuclide, or other moiety, as well as methods of treating cancer in a subject by administering to the subject a bispecific antigen-binding molecule or an ADC thereof.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: April 16, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Julian Andreev, Andres Perez Bay, Christopher Daly, Frank Delfino, Amy Han, Thomas Nittoli, William Olson, Gavin Thurston
  • Publication number: 20240101594
    Abstract: Described herein are protein steroid conjugates that are useful, for example, for the target-specific delivery of glucocorticoids (GCs) to cells.
    Type: Application
    Filed: July 28, 2023
    Publication date: March 28, 2024
    Inventors: Amy HAN, Andrew J. MURPHY, William OLSON
  • Publication number: 20240082617
    Abstract: A pump panel training device is provided and includes a plurality of simulated gages operable to imitate gages upon a fire truck pump panel, a plurality of simulated controls operable to imitate controls upon the fire truck pump panel, and a simulated water hose operable to imitate one of water temperature changes, water temperature pressure, and water hose vibration for the fire truck pump panel.
    Type: Application
    Filed: November 21, 2023
    Publication date: March 14, 2024
    Applicant: FAAC Incorporated
    Inventors: David S. Bouwkamp, William Martin, Nikolaos Dimitri Zachary Kazakos, James R. Mason, Dale Eammon Atkin, Travis Staley, Steven Olson, Joseph Lewis Clift, Stuart Ball, Philip C. Duczyminski
  • Patent number: 11925378
    Abstract: An ultrasonic surgical device is disclosed including a surgical tool including a proximal transducer mounting portion defining a surface, a distal end effector end, and a waveguide disposed therebetween, the waveguide extending along a longitudinal axis. The ultrasonic surgical device further includes a transducer is in mechanical communication with the surface of the transducer mounting portion. The transducer is configured to operate in a D31 mode with respect to the longitudinal axis of the waveguide. Upon activation by an electrical signal having a predetermined frequency component, the transducer is configured to induce a standing wave in the surgical tool to cause the end effector to vibrate, the standing wave having a wavelength proportional to the predetermined frequency component of the electrical signal.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: March 12, 2024
    Assignee: Cilag GmbH International
    Inventors: Jeffrey D. Messerly, Brian D. Black, William A. Olson, Foster B. Stulen, Frederick Estera, William E. Clem, Jerome R. Morgan, Jeffrey L. Aldridge, Stephen M. Leuck, Kevin L. Houser
  • Publication number: 20240076396
    Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.
    Type: Application
    Filed: September 6, 2023
    Publication date: March 7, 2024
    Inventors: Robert Babb, Drew Dudgeon, Yu Huang, Rosalynn Molden, William Olson, Matthew Sleeman, Dimitris Skokos, Bei Wang
  • Patent number: 11896682
    Abstract: Radiolabeled anti-MET antibodies and MET×MET bispecific antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of MET proteins in a subject or sample and methods of monitoring efficacy of treatment of a Met expressing tumor.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: February 13, 2024
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Marcus Kelly, Dangshe Ma, William Olson
  • Publication number: 20230348569
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Application
    Filed: June 29, 2023
    Publication date: November 2, 2023
    Inventors: Robert BABB, Alina BAUM, Gang CHEN, Cindy GERSON, Johanna HANSEN, Tammy HUANG, Christos KYRATSOUS, Wen-Yi LEE, Marine MALBEC, Andrew MURPHY, William OLSON, Neil STAHL, George D. YANCOPOULOS
  • Publication number: 20230330254
    Abstract: The present invention provides antibody-tethered drug conjugates (ATDCs) and compositions thereof that are useful, for example, for targeting glucagon-like peptide 1 receptor (GLP1R) and treating various conditions, e.g., diabetes. Methods for making such ATDCs are also provided along with method of use thereof.
    Type: Application
    Filed: March 11, 2023
    Publication date: October 19, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Haruka OKAMOTO, Jean YANOLATOS, AMY HAN, Xiang ZHENG, William OLSON, Andrew J. MURPHY, Frank DELFINO
  • Patent number: 11786291
    Abstract: An end-effector is disclosed. The end-effector includes a clamp arm and an ultrasonic blade configured to acoustically couple to an ultrasonic transducer and electrically couple to a pole of an electrical generator. The clamp arm includes a clamp jaw, a clamp arm pad, and a cantilever electrode that is free to deflect. The cantilever electrode is configured to electrically couple to an opposite pole of the electrical generator. Also disclosed are configurations where the clamp arm includes a peripheral cantilever electrode and a clamp arm pad extending beyond the electrode, a floating cantilever electrode and a resilient clamp arm pad, an interlocked cantilever electrode plate and a clamp arm pad configured to receive the plate, a laterally deflectable cantilever electrode and a clamp arm pad extending beyond the electrode, and a flexible cantilever electrode and a clamp arm pad extending beyond the electrode.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: October 17, 2023
    Assignee: Cilag GmbH International
    Inventors: John M. Sarley, Chad P. Boudreaux, Tyler N. Brehm, Wei Guo, Ellen E. Burkart, Jeffrey D. Messerly, Craig N. Faller, Robert S. Bishop, Michael A. Keenan, William A. Olson, Richard W. Flaker, Frederick E. Shelton, IV
  • Patent number: 11786603
    Abstract: Provided herein are methods and compositions for site-specific conjugation of antibodies in the presence of a transglutaminase.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: October 17, 2023
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Amy Han, William Olson, Christopher D'Souza
  • Patent number: 11787867
    Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: October 17, 2023
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Robert Babb, Drew Dudgeon, Yu Huang, Rosalynn Molden, William Olson, Matthew Sleeman, Dimitris Skokos, Bei Wang
  • Publication number: 20230320747
    Abstract: An apparatus comprises a body assembly and a shaft extending distally therefrom. The shaft defines a longitudinal axis. The apparatus further comprises an acoustic waveguide and an articulation section coupled with the shaft. A portion of the articulation section encompasses a flexible portion of the waveguide. The articulation section further comprises first member and a second member that is longitudinally translatable relative to the first member. The apparatus further comprises an end effector including an ultrasonic blade in acoustic communication with the waveguide. A distal portion the ultrasonic blade is disposed in a first direction away from the longitudinal axis at a bend angle. The end effector also includes a clamp arm that is coupled with the first member and the second member, and an articulation drive assembly operable to drive articulation of the articulation section to thereby deflect the end effector from the longitudinal axis in the first direction.
    Type: Application
    Filed: May 5, 2023
    Publication date: October 12, 2023
    Inventors: Foster B. Stulen, William A. Olson, William B. Weisenburgh, II
  • Patent number: 11780907
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: October 10, 2023
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
  • Patent number: 11760775
    Abstract: Described herein are protein steroid conjugates that are useful, for example, for the target-specific delivery of glucocorticoids (GCs) to cells.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: September 19, 2023
    Inventors: Amy Han, Andrew J. Murphy, William Olson
  • Publication number: 20230277205
    Abstract: The present disclosure is directed to end effectors. An end effector includes an outer shaft extending along a longitudinal axis and an inner shaft partially located within the outer shaft. The end effector may include an ultrasonic blade. The inner shaft may include biased and unbiased portions. The inner shaft and outer shaft may be translatable relative to one another. At one translatable position, the biased portion of the inner shaft may be located within the outer shaft and the unbiased portion may be substantially straight along the longitudinal axis. At another translatable position, the biased portion of the inner shaft may be located outside of and distally positioned from the outer shaft such that the biased portion of the inner shaft is bent away from the longitudinal axis.
    Type: Application
    Filed: February 17, 2023
    Publication date: September 7, 2023
    Inventors: William A. Olson, Jeffrey D. Messerly, Daniel W. Price, Kevin L. Houser, Craig N. Faller, William D. Dannaher, Sora Rhee, Tylor C. Muhlenkamp
  • Publication number: 20230270894
    Abstract: Radiolabeled anti-LAG3 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of LAG3 proteins in a patient or sample.
    Type: Application
    Filed: October 25, 2022
    Publication date: August 31, 2023
    Inventors: Marcus Kelly, Dangshe Ma, William Olson, Gavin Thurston, Richard Tavare
  • Publication number: 20230270837
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Application
    Filed: December 15, 2022
    Publication date: August 31, 2023
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • Patent number: 11732030
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 22, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Patent number: 11678903
    Abstract: An apparatus comprises a body assembly and a shaft extending distally therefrom. The shaft defines a longitudinal axis. The apparatus further comprises an acoustic waveguide and an articulation section coupled with the shaft. A portion of the articulation section encompasses a flexible portion of the waveguide. The articulation section further comprises first member and a second member that is longitudinally translatable relative to the first member. The apparatus further comprises an end effector including an ultrasonic blade in acoustic communication with the waveguide. A distal portion the ultrasonic blade is disposed in a first direction away from the longitudinal axis at a bend angle. The end effector also includes a clamp arm that is coupled with the first member and the second member, and an articulation drive assembly operable to drive articulation of the articulation section to thereby deflect the end effector from the longitudinal axis in the first direction.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: June 20, 2023
    Assignee: Cilag GmbH International
    Inventors: Foster B. Stulen, William A. Olson, William B. Weisenburgh, II